<DOC>
	<DOCNO>NCT01252589</DOCNO>
	<brief_summary>Although impact disease treatment related burden health-related quality life ( HRQOL ) patient solid tumours well study , several clinical trial include HRQOL endpoint , general understanding patient Chronic Myeloid Leukaemia ( CML ) lack comparison . The literature show patient ' perspective unique always measure methodologically sound instrument devise purpose . The main scope project develop international validated questionnaire purpose HRQOL assessment ; tool use provide important data , patient ' perspective , make informed treatment decision .</brief_summary>
	<brief_title>Patient Reported Outcomes Chronic Myeloid Leukemia</brief_title>
	<detailed_description>The development process follow international guideline publish EORTC Quality Life Group ( QLG ) . This process follow three main phase . Phase 1 deal review literature , identification item list interview expert treatment CML CML patient ( undergo possible treatment ) . In Phase II identify issue Phase I word translate possible item provisional questionnaire use exist EORTC questionnaire EORTC QLG Item Bank . In Phase III provisional CML questionnaire pre-tested large sample CML patient ( patient involve previous phase ) individual structure interview conduct well . These latter identify question might irrelevant whether additional issue previously include . Overall 480 patient enrol study ( 180 phase I 300 phase III ) .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myelogenous , Chronic , BCR-ABL Positive</mesh_term>
	<criteria>Adult patient ( 18 year age old ) Confirmed diagnosis Philadelphia chromosome positive CML Informed consent provide Patients enrolled investigational treatment trial eligible Ability speak read language Questionnaire Freedom overt cognitive impairment major psychiatric condition may confound HRQOL evaluation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Chronic Myeloid Leukemia</keyword>
	<keyword>Quality Life</keyword>
	<keyword>Symptoms</keyword>
	<keyword>Patient-Reported outcome</keyword>
	<keyword>Questionnaire</keyword>
</DOC>